News for Adagene Inc. (ADAG)

Transaction Overview On December 31, 2024, FIL Ltd (Trades, Portfolio), a renowned asset management firm, strategically increased its stake in Adagene Inc (ADAG

Muzastotug (ADG126), an Anti-CTLA-4 SAFEbody® in Combination with pembrolizumab showed 33% overall response rate in microsatellite stable colorectal cancer Fo

SAN DIEGO and SUZHOU, China, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (”œAdagene”) ( ADAG), a company transforming the discovery and development of n

Here is how Adagene Inc. Sponsored ADR (ADAG) and Editas Medicine (EDIT) have performed compared to their sector so far this year.

Shares of Adagene Inc. (ADAG) experienced significant volatility, dropping 5.97% to $1.89. The trading volume reached 26,937 shares with a turnover rate of 0.06

Here is how Adagene Inc. Sponsored ADR (ADAG) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

Here is how Adagene Inc. Sponsored ADR (ADAG) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

Adagene reports new findings at SITC meeting

The allogeneic hematopoietic stem cell transplant market is expected to experience significant growth in the coming years, driven by advances in...

Adagene Inc. (ADAG), a clinical-stage biopharmaceutical company, experienced a significant stock movement with a 5.43% surge in its share price. The stock is cu

Shares of Exicure, Inc. XCUR rose sharply in today's pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq c...

The stem cell market is experiencing positive growth due to several factors, including the increasing prevalence of chronic diseases, the need for drug...

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

HER2 negative Breast Cancer Pipeline involves 85+ key companies continuously working towards developing 85+ HER2 negative Breast Cancer treatment...

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding ...

Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates GlobeNewswire August 26, 2021 - Established three clinical collaborations with Merck to conduct global combination trials with pembrolizumab for three clinical-stage oncology candidates - For more information, please visit: https://investor.adagene.com. Safe Harbor Statement Internal Contact:Ami [email protected] External Contact: Bruce...

Point Roberts, WA and Delta, BC - April 30, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader res...

Here's a roundup of top developments in the biotech space over the last 24 hours: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...